---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-022881"
form_type: "8-K"
ticker: "CING"
cik: "0001862150"
company_name: "Cingulate Inc."
filed_at: "2026-05-14T12:10:16+00:00"
generated_at: "2026-05-14T12:16:00.402724+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cingulate Q1 net loss widens to $9.3M; cash at $25.9M; CTx-1301 PDUFA May 31

## Summary
- Net loss of $9.3M for Q1 2026, up from $3.9M a year ago; G&A expenses surged to $5.7M on commercial build-out.
- Cash and cash equivalents $25.9M at Mar 31, up $14.9M from Dec 31, extending runway into 2027.
- FDA review of CTx-1301 NDA ongoing; PDUFA target action date remains May 31, 2026.
- Commercial readiness advanced with AI-driven tools and IQVIA sales force agreement for potential launch.
- R&D expenses decreased 1.8% to $2.2M as clinical studies concluded, partly offset by regulatory and CMC activities.

## SEC filing metadata
- accession: 0001493152-26-022881
- form_type: 8-K
- ticker: CING
- cik: 0001862150
- company_name: Cingulate Inc.
- filed_at: 2026-05-14T12:10:16+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1862150/000149315226022881/0001493152-26-022881-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1862150/000149315226022881/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-022881
- JSON: https://secwatch.observer/filing/0001493152-26-022881.json
- Plain text: https://secwatch.observer/filing/0001493152-26-022881.txt

## Key facts
- Earnings Releases
  Cingulate Inc. reported the quarter ended March 31, 2026 results: net income Net loss was $9.3 million for the three months ended March 31, 2026.
  - Period: the quarter ended March 31, 2026
  - Net income: Net loss was $9.3 million for the three months ended March 31, 2026
  - Result: reported results
  source text: Cingulate Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026 and providing a business update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1862150/000149315226022881/0001493152-26-022881-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.